{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:36:56Z","timestamp":1787726216515,"version":"build-2784847793"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T00:00:00Z","timestamp":1634169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T00:00:00Z","timestamp":1634169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Racial and Ethnic Health Disparities"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s40615-021-01166-6","type":"journal-article","created":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T15:03:20Z","timestamp":1634223800000},"page":"2291-2299","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Impact of Medicaid Expansion Status and Race on Metastatic Disease at Diagnosis in Patients with Melanoma"],"prefix":"10.1007","volume":"9","author":[{"given":"Jesus C.","family":"Fabregas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin T.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Lutzky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"William Russell","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6654-739X","authenticated-orcid":false,"given":"Jeannine M.","family":"Brant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,14]]},"reference":[{"key":"1166_CR1","unstructured":"American Cancer Society. Available at: https:\/\/www.cancer.org\/cancer\/melanoma-skin-cancer\/about\/key-statistics.html. Accessed March 10, 2021."},{"key":"1166_CR2","unstructured":"Surveillance Epidemiology and End Results Program. Cancer Stat Facts. Available at: https:\/\/seer.cancer.gov\/statfacts\/html\/melan.html. Accessed September 10, 2020."},{"key":"1166_CR3","unstructured":"American Cancer Society. Cancer Facts and Figures 2020. American Cancer Society. Cancer Facts and Figures 2020 Web site. Available at: https:\/\/www.cancer.org\/research\/cancer-facts-statistics\/all-cancer-facts-figures\/cancer-facts-figures-2016.html. Accessed June 2, 2020."},{"key":"1166_CR4","unstructured":"National Cancer Institute. Cancer stat facts: cancer disparities. National Cancer Institute. Available at: https:\/\/seer.cancer.gov\/statfacts\/html\/disparities.html. Accessed July 8, 2020."},{"key":"1166_CR5","unstructured":"Office of Minority Health. African Americans and Cancer. US Department of Health and Human Services. Available at: https:\/\/minorityhealth.hhs.gov\/omh\/browse.aspx?lvl=4&lvlid=16. Accessed July 7, 2020."},{"issue":"3","key":"1166_CR6","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.jaad.2020.03.094","volume":"83","author":"R Tripathi","year":"2020","unstructured":"Tripathi R, Archibald LK, Mazmudar RS, et al. Racial differences in time to treatment for melanoma. J Am Acad Dermatol. 2020;83(3):854\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1166_CR7","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jaad.2019.05.079","volume":"81","author":"MLH Baranowski","year":"2019","unstructured":"Baranowski MLH, Yeung H, Chen SC, et al. Factors associated with time to surgery in melanoma: an analysis of the National Cancer Database. J Am Acad Dermatol. 2019;81(4):908\u201316.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"1166_CR8","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.jaad.2020.08.097","volume":"84","author":"Y Qian","year":"2021","unstructured":"Qian Y, Johannet P, Sawyers A, et al. The ongoing racial disparities in melanoma: an analysis of the Surveillance, Epidemiology, and End Results database (1975\u20132016). J Am Acad Dermatol. 2021;84(6):1585\u201393.","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"1166_CR9","doi-asserted-by":"publisher","first-page":"6333","DOI":"10.21873\/anticanres.13844","volume":"39","author":"D Boczar","year":"2019","unstructured":"Boczar D, Restrepo DJ, Sisti A, et al. Analysis of Melanoma in African American Patients in the United States. Anticancer Res. 2019;39(11):6333\u20137.","journal-title":"Anticancer Res"},{"issue":"6","key":"1166_CR10","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/CJI.0000000000000264","volume":"42","author":"W Haque","year":"2019","unstructured":"Haque W, Verma V, Butler EB, Teh BS. Racial and socioeconomic disparities in the delivery of immunotherapy for metastatic melanoma in the United States. J Immunother. 2019;42(6):228\u201335.","journal-title":"J Immunother"},{"issue":"4","key":"1166_CR11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1177\/107327481402100411","volume":"21","author":"VM Harvey","year":"2014","unstructured":"Harvey VM, Patel H, Sandhu S, et al. Social determinants of racial and ethnic disparities in cutaneous melanoma outcomes. Cancer Control. 2014;21(4):343\u20139.","journal-title":"Cancer Control"},{"issue":"10","key":"1166_CR12","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1111\/ijd.14026","volume":"57","author":"JL Sitenga","year":"2018","unstructured":"Sitenga JL, Aird G, Ahmed A, et al. Socioeconomic status and survival for patients with melanoma in the United States: an NCDB analysis. Int J Dermatol. 2018;57(10):1149\u201356.","journal-title":"Int J Dermatol"},{"issue":"11","key":"1166_CR13","doi-asserted-by":"publisher","first-page":"6359","DOI":"10.21873\/anticanres.13848","volume":"39","author":"DJ Restrepo","year":"2019","unstructured":"Restrepo DJ, Huayllani MT, Boczar D, et al. Biopsy type disparities in patients with melanoma: who receives the standard of care? Anticancer Res. 2019;39(11):6359\u201363.","journal-title":"Anticancer Res"},{"issue":"6","key":"1166_CR14","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1377\/hlthaff.2017.1491","volume":"37","author":"O Mazurenko","year":"2018","unstructured":"Mazurenko O, Balio CP, Agarwal R, et al. The effects of medicaid expansion under the ACA: a systematic review. Health Aff (Millwood). 2018;37(6):944\u201350.","journal-title":"Health Aff (Millwood)"},{"key":"1166_CR15","unstructured":"American College of Surgeons. National Cancer Database. Available at: https:\/\/www.facs.org\/Quality-Programs\/Cancer\/NCDB. Accessed March 10, 2020."},{"issue":"6","key":"1166_CR16","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","volume":"45","author":"RA Deyo","year":"1992","unstructured":"Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"1166_CR17","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jacc.2016.10.060","volume":"69","author":"MC Elze","year":"2017","unstructured":"Elze MC, Gregson J, Baber U, et al. Comparison of propensity score methods and covariate adjustment: evaluation in 4 cardiovascular studies. J Am Coll Cardiol. 2017;69(3):345\u201357.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"1166_CR18","first-page":"575","volume":"15","author":"F Kamangar","year":"2012","unstructured":"Kamangar F. Effect modification in epidemiology and medicine. Arch Iran Med. 2012;15(9):575\u201382.","journal-title":"Arch Iran Med"},{"issue":"1","key":"1166_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/sj.bjc.6601907","volume":"91","author":"A Burton","year":"2004","unstructured":"Burton A, Altman DG. Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines. Br J Cancer. 2004;91(1):4\u20138.","journal-title":"Br J Cancer"},{"issue":"12","key":"1166_CR20","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","volume":"12","author":"E von Elm","year":"2014","unstructured":"von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495\u20139.","journal-title":"Int J Surg"},{"issue":"6","key":"1166_CR21","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3322\/caac.21577","volume":"69","author":"CE DeSantis","year":"2019","unstructured":"DeSantis CE, Miller KD, Dale W, et al. Cancer statistics for adults aged 85 years and older, 2019. CA Cancer J Clin. 2019;69(6):452\u201367.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"1166_CR22","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.jaad.2019.01.003","volume":"80","author":"ZH Hopkins","year":"2019","unstructured":"Hopkins ZH, Moreno C, Carlisle R, Secrest AM. Melanoma prognosis in the United States: Identifying barriers for improved care. J Am Acad Dermatol. 2019;80(5):1256\u201362.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1166_CR23","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.jaad.2020.05.088","volume":"83","author":"S Rachidi","year":"2020","unstructured":"Rachidi S, Deng Z, Sullivan DY, Lipson EJ. Shorter survival and later stage at diagnosis among unmarried patients with cutaneous melanoma: a US national and tertiary care center study. J Am Acad Dermatol. 2020;83(4):1012\u201320.","journal-title":"J Am Acad Dermatol"},{"key":"1166_CR24","unstructured":"National Research Council (US); Institute of Medicine (US); Woolf SH, Aron L, editors. U.S. Health in international perspective: shorter lives, poorer health. Washington (DC): National Academies Press (US); 2013. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK115854\/. Accessed September 2020."},{"key":"1166_CR25","doi-asserted-by":"crossref","unstructured":"Sanchez DP, Maymone MBC, McLean EO, et al. Racial and ethnic disparities in melanoma awareness: a cross-sectional survey. J Am Acad Dermatol. 2020.","DOI":"10.1016\/j.jaad.2020.04.137"},{"issue":"4","key":"1166_CR26","first-page":"353","volume":"20","author":"RM Merrill","year":"2010","unstructured":"Merrill RM, Pace ND, Elison AN. Cutaneous malignant melanoma among white Hispanics and non-Hispanics in the United States. Ethn Dis. 2010;20(4):353\u20138.","journal-title":"Ethn Dis"},{"issue":"4","key":"1166_CR27","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/jid.2013.465","volume":"134","author":"S Hu","year":"2014","unstructured":"Hu S, Sherman R, Arheart K, Kirsner RS. Predictors of neighborhood risk for late-stage melanoma: addressing disparities through spatial analysis and area-based measures. J Invest Dermatol. 2014;134(4):937\u201345.","journal-title":"J Invest Dermatol"},{"issue":"12","key":"1166_CR28","doi-asserted-by":"publisher","first-page":"6877","DOI":"10.21873\/anticanres.13906","volume":"39","author":"D Boczar","year":"2019","unstructured":"Boczar D, Restrepo DJ, Sisti A, et al. Disparity on unplanned readmission in melanoma patients: a national cancer database analysis. Anticancer Res. 2019;39(12):6877\u201380.","journal-title":"Anticancer Res"},{"issue":"2","key":"1166_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000468152","volume":"95","author":"Z Al-Qurayshi","year":"2018","unstructured":"Al-Qurayshi Z, Srivastav S, Wang A, et al. Disparities in the presentation and management of cutaneous melanoma that required admission. Oncology. 2018;95(2):69\u201380.","journal-title":"Oncology"},{"issue":"4","key":"1166_CR30","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/cncr.32587","volume":"126","author":"B Abudu","year":"2020","unstructured":"Abudu B, Cook KA, Gershenwald JE, et al. Quantitative associations between health insurance and stage of melanoma at diagnosis among nonelderly adults in the United States. Cancer. 2020;126(4):775\u201381.","journal-title":"Cancer"},{"issue":"1","key":"1166_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/CJI.0000000000000294","volume":"43","author":"V Jain","year":"2020","unstructured":"Jain V, Venigalla S, Reddy VK, et al. Association of insurance status with presentation, treatment, and survival in melanoma in the era of immune checkpoint inhibitors. J Immunother. 2020;43(1):8\u201315.","journal-title":"J Immunother"},{"issue":"4","key":"1166_CR32","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1177\/1203475419847955","volume":"23","author":"M Dick","year":"2019","unstructured":"Dick M, Aurit S, Silberstein P. The odds of stage IV melanoma diagnoses based on socioeconomic factors. J Cutan Med Surg. 2019;23(4):421\u20137.","journal-title":"J Cutan Med Surg"},{"issue":"35","key":"1166_CR33","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1200\/JCO.2017.73.7817","volume":"35","author":"A Jemal","year":"2017","unstructured":"Jemal A, Lin CC, Davidoff AJ, Han X. Changes in insurance coverage and stage at diagnosis among nonelderly patients with cancer after the affordable care act. J Clin Oncol. 2017;35(35):3906\u201315.","journal-title":"J Clin Oncol"},{"issue":"9","key":"1166_CR34","doi-asserted-by":"publisher","first-page":"e2015656","DOI":"10.1001\/jamanetworkopen.2020.15656","volume":"3","author":"JT Moyers","year":"2020","unstructured":"Moyers JT, Patel A, Shih W, Nagaraj G. Association of sociodemographic factors with immunotherapy receipt for metastatic melanoma in the US. JAMA Netw Open. 2020;3(9):e2015656.","journal-title":"JAMA Netw Open."},{"issue":"6","key":"1166_CR35","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.jaad.2021.01.097","volume":"84","author":"RJ Straker 3rd","year":"2021","unstructured":"Straker RJ 3rd, Song Y, Shannon AB, et al. Association of the Affordable Care Act\u2019s Medicaid expansion with the diagnosis and treatment of clinically localized melanoma: a National Cancer Database study. J Am Acad Dermatol. 2021;84(6):1628\u201335.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1166_CR36","doi-asserted-by":"publisher","first-page":"E502","DOI":"10.9778\/cmajo.20180089","volume":"6","author":"ME Mavor","year":"2018","unstructured":"Mavor ME, Richardson H, Miao Q, et al. Disparities in diagnosis of advanced melanoma: a population-based cohort study. CMAJ Open. 2018;6(4):E502-e512.","journal-title":"CMAJ Open"},{"issue":"4","key":"1166_CR37","doi-asserted-by":"publisher","first-page":"e13043","DOI":"10.1111\/ecc.13043","volume":"28","author":"M Guevara","year":"2019","unstructured":"Guevara M, Rodr\u00edguez-Barranco M, Puigdemont M, et al. Disparities in the management of cutaneous malignant melanoma. A population-based high-resolution study. Eur J Cancer Care (Engl). 2019;28(4):e13043.","journal-title":"Eur J Cancer Care (Engl)."},{"issue":"8","key":"1166_CR38","doi-asserted-by":"publisher","first-page":"993","DOI":"10.3109\/0284186X.2016.1144934","volume":"55","author":"U Str\u00f6mberg","year":"2016","unstructured":"Str\u00f6mberg U, Peterson S, Holmberg E, et al. Cutaneous malignant melanoma show geographic and socioeconomic disparities in stage at diagnosis and excess mortality. Acta Oncol. 2016;55(8):993\u20131000.","journal-title":"Acta Oncol"},{"key":"1166_CR39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ejca.2015.11.019","volume":"55","author":"J Barbaric","year":"2016","unstructured":"Barbaric J, Sekerija M, Agius D, et al. Disparities in melanoma incidence and mortality in South-Eastern Europe: increasing incidence and divergent mortality patterns. Is progress around the corner? Eur J Cancer. 2016;55:47\u201355.","journal-title":"Eur J Cancer."},{"key":"1166_CR40","doi-asserted-by":"crossref","unstructured":"Masri A, Steinmetz L, Robinson III W. Impact of the Affordable Care \u0391ct on cervical cancer trends in \u039dew \u039frleans. Gynecol Oncol. 2020;159(2, E10).","DOI":"10.1016\/j.ygyno.2020.07.042"},{"issue":"1","key":"1166_CR41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.amepre.2008.03.026","volume":"35","author":"RA Pollitt","year":"2008","unstructured":"Pollitt RA, Clarke CA, Shema SJ, Swetter SM. California Medicaid enrollment and melanoma stage at diagnosis: a population-based study. Am J Prev Med. 2008;35(1):7\u201313.","journal-title":"Am J Prev Med"},{"issue":"1","key":"1166_CR42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/SLA.0000000000004451","volume":"273","author":"MR Poulson","year":"2021","unstructured":"Poulson MR, Beaulieu-Jones BR, Kenzik KM, et al. Residential racial segregation and disparities in breast cancer presentation, treatment, and survival. Ann Surg. 2021;273(1):3\u20139.","journal-title":"Ann Surg"}],"container-title":["Journal of Racial and Ethnic Health Disparities"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-021-01166-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40615-021-01166-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-021-01166-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T15:27:01Z","timestamp":1667489221000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40615-021-01166-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,14]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1166"],"URL":"https:\/\/doi.org\/10.1007\/s40615-021-01166-6","relation":{},"ISSN":["2197-3792","2196-8837"],"issn-type":[{"value":"2197-3792","type":"print"},{"value":"2196-8837","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,14]]},"assertion":[{"value":"15 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This data-only study was approved with waiver of consent by the Billings Clinic Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Authors Jesus C. Fabregas, Benjamin T. Carter, and William Russell Robinson, III, have no financial interests to disclose. Jose Lutzky reported consulting or advisory roles for Castle Biosciences, Iovance Biotherapeutics, Replimune, and Regeneron. Jeannine M. Brant reported serving on the Speakers\u2019 Bureau for Daiichi Sankyo\/Astra Zeneca.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}